Hemispherx Biopharma (NYSE: HEB) disclosed in an SEC filing:On February 17, 2016, the Board of Directors (the “Board”) of Hemispherx ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE